113 related articles for article (PubMed ID: 7976566)
1. Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
Park CK; McCulloch J; Jung DS; Kang JK; Choi CR
Acta Neurochir Suppl (Wien); 1994; 60():279-81. PubMed ID: 7976566
[TBL] [Abstract][Full Text] [Related]
2. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.
Park CK; McCulloch J; Kang JK; Choi CR
Acta Neurochir (Wien); 1994; 127(3-4):220-6. PubMed ID: 7942207
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on cerebral oedema, cerebral infarction and neuroprotective potential in experimental occlusive stroke.
Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
Acta Neurochir Suppl (Wien); 1994; 60():282-4. PubMed ID: 7976568
[TBL] [Abstract][Full Text] [Related]
4. Experimental stroke and neuroprotection in the aging rat brain.
Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
Stroke; 1995 Jun; 26(6):1072-8. PubMed ID: 7762026
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
Chen M; Bullock R; Graham DI; Frey P; Lowe D; McCulloch J
Ann Neurol; 1991 Jul; 30(1):62-70. PubMed ID: 1834008
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat.
Park CK; McCulloch J; Kang JK; Choi CR
Neurosci Lett; 1992 Nov; 147(1):41-4. PubMed ID: 1480321
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia.
Başkaya MK; Rao AM; Donaldson D; Prasad MR; Dempsey RJ
Neurosurgery; 1997 Feb; 40(2):364-70; discussion 370-1. PubMed ID: 9007871
[TBL] [Abstract][Full Text] [Related]
8. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD
Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675
[TBL] [Abstract][Full Text] [Related]
9. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the relationship between ischemic damage and brain swelling in frozen brain slices.
Park CK; Jun SS; Cho SH; Kang JK
Acta Neurochir Suppl; 1997; 70():17-9. PubMed ID: 9416265
[TBL] [Abstract][Full Text] [Related]
11. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
12. Early evolution and recovery from excitotoxic injury in the neonatal rat brain: a study combining magnetic resonance imaging, electrical impedance, and histology.
van Lookeren Campagne M; Verheul JB; Nicolay K; Balázs R
J Cereb Blood Flow Metab; 1994 Nov; 14(6):1011-23. PubMed ID: 7929643
[TBL] [Abstract][Full Text] [Related]
13. Reduction of vasogenic edema and infarction by MK-801 in rats after temporary focal cerebral ischemia.
Yang G; Chan PH; Chen SF; Babuna OA; Simon RP; Weinstein PR
Neurosurgery; 1994 Feb; 34(2):339-45; discussion 345. PubMed ID: 8177396
[TBL] [Abstract][Full Text] [Related]
14. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
15. Effects of a novel NMDA receptor antagonist on experimental stroke quantitatively assessed by spectral EEG and infarct volume.
Cohen RA; Hasegawa Y; Fisher M
Neurol Res; 1994 Dec; 16(6):443-8. PubMed ID: 7708135
[TBL] [Abstract][Full Text] [Related]
16. The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.
Hasegawa Y; Fisher M; Baron BM; Metcalf G
Stroke; 1994 Jun; 25(6):1241-4; discussion 1245-6. PubMed ID: 8202987
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study.
Sauer D; Allegrini PR; Cosenti A; Pataki A; Amacker H; Fagg GE
J Cereb Blood Flow Metab; 1993 Jul; 13(4):595-602. PubMed ID: 8100238
[TBL] [Abstract][Full Text] [Related]
18. Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
Bullock R; Graham DI; Chen MH; Lowe D; McCulloch J
J Cereb Blood Flow Metab; 1990 Sep; 10(5):668-74. PubMed ID: 2166743
[TBL] [Abstract][Full Text] [Related]
19. Effect of CP101,606, a novel NR2B subunit antagonist of the N-methyl-D-aspartate receptor, on the volume of ischemic brain damage off cytotoxic brain edema after middle cerebral artery occlusion in the feline brain.
Di X; Bullock R; Watson J; Fatouros P; Chenard B; White F; Corwin F
Stroke; 1997 Nov; 28(11):2244-51. PubMed ID: 9368572
[TBL] [Abstract][Full Text] [Related]
20. Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia.
Vakili A; Hosseinzadeh F; Sadogh T
Brain Res; 2007 Sep; 1170():97-102. PubMed ID: 17698046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
